Table 1.
Characteristics of surgical patients.
| Patient characteristics | NSR | CAF |
|---|---|---|
| Patients, n | 46 | 39 |
| Male/Female | 20/26 | 18/21 |
| Age, years | 40.32±2.10 | 59.40±5.733* |
| Previous history | ||
| CAD, n (%) | 6 (13.04) | 7 (17.94) |
| MVD or AVD, n (%) | 32 (69.56) | 30 (76.92) |
| Hypertension, n (%) | 21 (45.6) | 22 (56.4) |
| Diabetes mellitus, n | 3 (6.52) | 4 (10.25) |
| NYHA functional class, n | ||
| II, n (%) | 29 (63.04) | 5 (12.82)* |
| III, n (%) | 16 (34.78) | 30 (76.9)* |
| IV, n (%) | 1 (2.17) | 4 (10.25)* |
| Echocardiography | ||
| LVEF, % | 56.4±3.1 | 46.6±2.9 |
| LAD, mm | 41.1±2.7 | 54.9±4.1* |
| LVEDD, mm | 52.3±2.4 | 50.2±2.6 |
| IVS | 10.2±0.8 | 8.4±0.7 |
| LVPW | 10.3±0.6 | 9.1±0.5 |
| Medication, n (%) | ||
| Digitalis | 5 (10.86) | 6 (15.38) |
| ACEI/ATRBs | 24 (52.17) | 23 (58.97) |
| β-blockers | 25 (54.34) | 24 (61.53) |
| Diuretics | 13 (28.26) | 15 (38.46) |
| Lipid-lowering drugs | 22 (47.82) | 25 (64.10*) |
| Calcium channels antagonists | 4 (8.69) | 4 (10.25) |
n represents the number of patients, and the percentage represents the percentage of total patients. Data are presented as the mean±SEM.
*
P<0.05 versus NSR.
CAD – coronary artery disease; MVD – mitral valve disease; AVD – aortic valve disease; LVEF – left ventricular ejection fraction; LAD – left atrial diameter; LVEDD – left ventricular end-diastolic diameter; IVS – interventricular septum thickness; LVPW – left ventricular posterior wall thickness; ACEI – angiotensin-converting enzyme inhibitor. ATRBs, angiotensin receptor blockers. SEM, standard error of the mean.